EDGAR Filing Documents for 0001213900-17-007102

Form 424B5 - Prospectus [Rule 424(b)(5)]:

SEC Accession No. 0001213900-17-007102

Filing Date

2017-07-03

Accepted

2017-07-03 16:19:35

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	PROSPECTUS SUPPLEMENT	f424b5070317_actinium.htm	424B5	485470
2	GRAPHIC	img_001.jpg	GRAPHIC	25442
3	GRAPHIC	logo_001.jpg	GRAPHIC	25337
	Complete submission text file	0001213900-17-007102.txt		556746

Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016

Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875

Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)